80 likes | 260 Views
ADCIRCA. Prepared by : Areen zraiqah. Drug Name : ADCIRCA ( TADALAFIL) Company : Eli Lilly Approved status : approved May 2009 Treatment area : Pulmonary Arterial Hypertension. More about adcirca :.
E N D
ADCIRCA Prepared by : Areen zraiqah
Drug Name : ADCIRCA ( TADALAFIL) Company : Eli Lilly Approved status : approved May 2009 Treatment area : Pulmonary Arterial Hypertension
More about adcirca : Dosage form : tablet “ orally “ Bioavailability : varies Protein binding : 94% T1\2: 17.5 hours Metabolism : by Liver Execration : in feces (61%) , in urine (36%)
Mechanism of action : Adcirca (tadalafil) is an oral inhibitor of phosphodiesterase type 5 (PDE5), the enzyme responsible for the degradation of cyclic guanosine monophosphate (cGMP). Pulmonary arterial hypertension is associated with impaired release of nitric oxide by the vascular endothelium and consequent reduction of cGMP concentrations in the pulmonary vascular smooth muscle. PDE5 is the predominant phosphodiesterase in the pulmonary vasculature. Inhibition of PDE5 by tadalafil increases the concentrations of cGMP resulting in relaxation of pulmonary vascular smooth muscle cells and vasodilation of the pulmonary vascular bed.
Contraindication : You can’t take this drug if : You take other drugs contain nitrate . Taking Rifampin . You allergic to tadalafil . You are allergic to tadalafil .